Expanding Options for Menopausal Symptoms
Hot flashes remain the single most frequent symptom experienced during perimenopause and menopause, impacting roughly 75% to 85% of women. While traditional hormone therapies have long been utilized, recent years have marked a notable spike in the development and exploration of nonhormone alternatives to help patients manage these disruptive vasomotor symptoms safely and effectively.
The emerging evaluation of transdermal nitroglycerin patches contributes to this growing landscape of nonhormone treatments, offering a fresh avenue for clinical research and patient care.

